Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Virtual Training For AAA Graft Procedure In HT Medical Systems Pipeline

This article was originally published in The Gray Sheet

Executive Summary

HT Medical Systems says it is developing a generic simulation system for abdominal aortic aneurysm stent graft placement training that would apply to a number of AAA devices.

You may also be interested in...



Joint Arthroplasty Endpoints Fitting For Computer-Assisted Surgery Devices

FDA should evaluate computer-assisted surgical technologies with endpoints currently used to review traditional total joint arthroplasty, the agency's Orthopedic and Rehabilitation Devices Panel advised at a Nov. 4 meeting in Rockville, Maryland.

Joint Arthroplasty Endpoints Fitting For Computer-Assisted Surgery Devices

FDA should evaluate computer-assisted surgical technologies with endpoints currently used to review traditional total joint arthroplasty, the agency's Orthopedic and Rehabilitation Devices Panel advised at a Nov. 4 meeting in Rockville, Maryland.

Guidant, Medtronic AAA Grafts Approved By FDA; Guidant Begins Shipments

Guidant has begun shipping its Ancure endovascular graft for treatment of abdominal aortic aneurysm, and Medtronic is expected to launch its AneuRx AAA device shortly once the company's surgeon training program is finalized. FDA simultaneously approved the two devices on Sept. 28.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel